Capital Growth Management’s MetLife MET Stock Holding History

Capital Growth Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-495,000	Closed	-$34.8M	–	79
2022 Q1	$34.8M	Buy	+495,000	New	+$33.5M	3.21%	11
2016 Q4	–	Sell	-179,520	Closed	-$7.11M	–	67
2016 Q3	$7.11M	Buy	+179,520	New	+$6.75M	0.34%	46
2016 Q1	–	Sell	-72,930	Closed	-$3.13M	–	65
2015 Q4	$3.13M	Sell	72,930 -409,530	-85%	-$18M	0.11%	51
2015 Q3	$20.3M	Sell	482,460 -1,548,360	-76%	-$72.3M	0.65%	36
2015 Q2	$101M	Buy	+2,030,820	New	+$96.2M	2.9%	9
2014 Q4	–	Sell	-145,860	Closed	-$6.98M	–	70
2014 Q3	$6.98M	Sell	145,860 -336,600	-70%	-$16.3M	0.2%	53
2014 Q2	$23.9M	Buy	482,460 +325,380	+207%	+$15.2M	0.63%	44
2014 Q1	$7.39M	Buy	+157,080	New	+$7.22M	0.2%	61
2013 Q4	–	Sell	-89,760	Closed	-$3.76M	–	80
2013 Q3	$3.76M	Buy	+89,760	New	+$3.87M	0.1%	58

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Growth Management's MET Position: Q2 2022 in Review

Capital Growth Management sold out of MetLife (MET) in Q2 2022, closing a stake of 495,000 shares — an estimated $34.8M sold.

Capital Growth Management first reported a position in MET in Q3 2013 and held it in 9 quarters. The position peaked at $101M in Q2 2015. 1,199 funds tracked by Wall St. Rank hold MET as of Q2 2022.

Capital Growth Management reported no remaining MetLife position as of Q2 2022 after selling out during the quarter.
Capital Growth Management sold 495,000 MetLife shares in Q2 2022, an estimated $34.8M.
Capital Growth Management first reported a position in MetLife in Q3 2013 and held it in 9 quarters.
Capital Growth Management's MetLife position peaked at $101M in Q2 2015.
1,199 funds tracked by Wall St. Rank held MetLife as of Q2 2022.

Based on Capital Growth Management's 13F filing for Q2 2022, filed 12 Aug 2022.